MedPath

Pharmaceutical Companies

KALA PHARMACEUTICALS INC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$27.9M
Website
-

Janison Education Group Ltd

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
165
Market Cap
$27.1M
Website
-
Janison Education Group Ltd operates in the education technology sector. Its primary activities include software development and the provision of Software-as-a-Service. The company operates in two segments including Assessment and...
BioXcel Therapeutics logo

BioXcel Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2017-01-01
Employees
74
Market Cap
$26.8M
Website
http://www.bioxceltherapeutics.com
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop...

VYNE THERAPEUTICS INC

๐Ÿ‡ฎ๐Ÿ‡ฑIsrael
Ownership
-
Established
-
Employees
-
Market Cap
$26.5M
Website
-

Iterum Therapeutics Inc

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$25.4M
Website
-

ACASTI PHARMA INC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$25.1M
Website
-

Brainstorm Cell Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
29
Market Cap
$25M
Website
-
Biora Therapeutics logo

Biora Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public, Subsidiary
Established
2010-01-01
Employees
58
Market Cap
$25M
Website
http://www.bioratherapeutics.com
Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal...
Vincerx Pharma logo

Vincerx Pharma

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2018-01-01
Employees
42
Market Cap
$23.7M
Website
http://vincerx.com
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical...
NanoViricides logo

NanoViricides

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2005-01-01
Employees
7
Market Cap
$23.7M
Website
http://www.nanoviricides.com
ยฉ Copyright 2025. All Rights Reserved by MedPath